Chemomab Therapeutics Ltd. Current Assets
Chemomab Therapeutics Ltd. (CMMB) had Current Assets of $13.43 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-03-23
- 2025-12-31: Assets, Current $13.43M.
- 2025-06-30: Assets, Current $10.61M.
- 2024-12-31: Assets, Current $16.04M.
- 2024-06-30: Assets, Current $13.46M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2025-12-31 | $13.43M 20-F · filed 2026-03-23 | |
| 2025-06-30 | $10.61M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $16.04M 20-F · filed 2026-03-23 | |
| 2024-06-30 | $13.46M 6-K · filed 2024-08-21 | |
| 2023-12-31 | $20.90M 20-F · filed 2025-04-04 | |
| 2023-06-30 | $27.70M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $33.78M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $41.74M 20-F · filed 2024-03-28 | |
| 2022-09-30 | $48.73M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $54.83M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $59.34M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $62.69M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $65.84M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $68.83M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $59.52M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $11.84M 10-K · filed 2022-03-30 | $6.12M 10-K · filed 2021-03-09 |
| 2020-09-30 | $7.39M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $9.67M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $14.68M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $18.21M 10-K · filed 2021-03-09 | |
| 2018-12-31 | $10.92M 10-K · filed 2020-03-17 |